PTC Therapeutics (PTCT)
78.40
-0.10 (0.13%)
Upcoming Events
Latest Headlines
Raymond James sees potential for beats across biopharma coverage
July 21, 2026 6:12 AM - StreetInsider
PTC Therapeutics (PTCT) PT Lowered to $93 at Wells Fargo
July 20, 2026 6:30 AM - StreetInsider
Form 4 PTC THERAPEUTICS, INC. For: Jul 14 Filed by: Gravier Pierre
July 16, 2026 5:21 PM - SEC Filing
PTC Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, July 30, 2026
July 16, 2026 8:00 AM - PR NewsWire
PTC Therapeutics (PTCT) PT Raised to $130 at Cantor Fitzgerald on PKU Launch
July 16, 2026 7:23 AM - StreetInsider
PTC Therapeutics (PTCT) Reiterated at Overweight by Cantor Fitzgerald
July 15, 2026 7:51 AM - StreetInsider
Form 144 PTC THERAPEUTICS, INC. Filed by: Gravier Pierre
July 14, 2026 3:14 PM - SEC Filing
Form 4 PTC THERAPEUTICS, INC. For: Jul 09 Filed by: Almstead Neil Gregory
July 13, 2026 5:20 PM - SEC Filing
Form 4 PTC THERAPEUTICS, INC. For: Jul 09 Filed by: Smith Mary L.
July 13, 2026 5:20 PM - SEC Filing
Form 144 PTC THERAPEUTICS, INC. Filed by: Almstead Neil Gregory
July 9, 2026 4:12 PM - SEC Filing
Form 144 PTC THERAPEUTICS, INC. Filed by: Smith Mary L.
July 9, 2026 12:19 PM - SEC Filing
Form 4 PTC THERAPEUTICS, INC. For: Jul 06 Filed by: Boulding Mark Elliott
July 8, 2026 5:20 PM - SEC Filing
Form 4 PTC THERAPEUTICS, INC. For: Jul 06 Filed by: Almstead Neil Gregory
July 8, 2026 5:20 PM - SEC Filing
Form 144 PTC THERAPEUTICS, INC. Filed by: Almstead Neil Gregory
July 7, 2026 4:11 PM - SEC Filing
PTC Therapeutics (PTCT) PT Raised to $85 at RBC Capital
July 7, 2026 7:55 AM - StreetInsider
Form 144 PTC THERAPEUTICS, INC. Filed by: Almstead Neil Gregory
July 6, 2026 4:11 PM - SEC Filing
Form 144 PTC THERAPEUTICS, INC. Filed by: Boulding Mark Elliott
July 6, 2026 3:18 PM - SEC Filing
Form 4 PTC THERAPEUTICS, INC. For: Jun 26 Filed by: Almstead Neil Gregory
June 30, 2026 5:20 PM - SEC Filing
Form 4 PTC THERAPEUTICS, INC. For: Jun 24 Filed by: Almstead Neil Gregory
June 26, 2026 5:20 PM - SEC Filing
Form 144 PTC THERAPEUTICS, INC. Filed by: Almstead Neil Gregory
June 26, 2026 3:29 PM - SEC Filing
Form 144 PTC THERAPEUTICS, INC. Filed by: Almstead Neil Gregory
June 25, 2026 4:17 PM - SEC Filing
Form 4 PTC THERAPEUTICS, INC. For: Jun 22 Filed by: Almstead Neil Gregory
June 24, 2026 5:20 PM - SEC Filing
Form 144 PTC THERAPEUTICS, INC. Filed by: Almstead Neil Gregory
June 24, 2026 4:12 PM - SEC Filing
Form 4 PTC THERAPEUTICS, INC. For: Jun 17 Filed by: Utter Christine Marie
June 22, 2026 5:20 PM - SEC Filing
Form 4 PTC THERAPEUTICS, INC. For: Jun 17 Filed by: Boulding Mark Elliott
June 22, 2026 5:20 PM - SEC Filing
Form 144 PTC THERAPEUTICS, INC. Filed by: Almstead Neil Gregory
June 22, 2026 4:25 PM - SEC Filing
Form 8-K PTC THERAPEUTICS, INC. For: Jun 18
June 18, 2026 4:15 PM - SEC Filing
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 17, 2026 4:30 PM - PR NewsWire
Form 144 PTC THERAPEUTICS, INC. Filed by: Boulding Mark Elliott
June 17, 2026 4:09 PM - SEC Filing
Form 144 PTC THERAPEUTICS, INC. Filed by: Utter Christine Marie
June 17, 2026 9:40 AM - SEC Filing
Form 8-K PTC THERAPEUTICS, INC. For: Jun 15
June 16, 2026 7:00 AM - SEC Filing
PTC Therapeutics prices $500M convertible notes at 0% to refinance 2026 debt
June 16, 2026 3:54 AM - StreetInsider
PTC Therapeutics Announces Pricing of Convertible Notes Offering to Refinance 2026 Convertible Notes
June 15, 2026 11:14 PM - PR NewsWire
PTC Therapeutics proposes $500 million convertible notes offering
June 15, 2026 7:00 AM - StreetInsider
PTC Therapeutics Announces Proposed Convertible Notes Offering to Refinance 2026 Convertible Notes
June 15, 2026 7:00 AM - PR NewsWire
Form 4 PTC THERAPEUTICS, INC. For: Jun 10 Filed by: Pauwels Eric
June 12, 2026 5:30 PM - SEC Filing
Form 144 PTC THERAPEUTICS, INC. Filed by: Pauwels Eric
June 10, 2026 12:51 PM - SEC Filing
Form 8-K PTC THERAPEUTICS, INC. For: Jun 08
June 9, 2026 5:15 PM - SEC Filing
Citi Assumes PTC Therapeutics (PTCT), Upgrades to Buy
June 9, 2026 5:01 AM - StreetInsider
Form 8-K PTC THERAPEUTICS, INC. For: Jun 02
June 5, 2026 5:15 PM - SEC Filing
Jefferies Upgrades PTC Therapeutics (PTCT) to Buy, 'deep dive suggests Sephience should continue to beat expectations'
May 27, 2026 8:52 AM - StreetInsider
BofA on PTC Therapeutics (PTCT): 'See opportunity for >$2bn in global Sephience sales'
May 20, 2026 10:46 AM - StreetInsider
Form 4 PTC THERAPEUTICS, INC. For: May 15 Filed by: Boulding Mark Elliott
May 19, 2026 5:20 PM - SEC Filing
Form 4 PTC THERAPEUTICS, INC. For: May 13 Filed by: Klein Matthew B.
May 15, 2026 5:20 PM - SEC Filing
Form SCHEDULE 13G/A PTC THERAPEUTICS, INC. Filed by: TORONTO DOMINION BANK
May 15, 2026 1:47 PM - SEC Filing
Form SCHEDULE 13G/A PTC THERAPEUTICS, INC. Filed by: JANUS HENDERSON GROUP PLC
May 15, 2026 12:39 PM - SEC Filing
Form 144 PTC THERAPEUTICS, INC. Filed by: Boulding Mark Elliott
May 15, 2026 10:08 AM - SEC Filing
Form 144 PTC THERAPEUTICS, INC. Filed by: Klein Matthew B.
May 14, 2026 3:10 PM - SEC Filing
Form 144 PTC THERAPEUTICS, INC. Filed by: Klein Matthew B.
May 14, 2026 12:44 PM - SEC Filing
Form 4 PTC THERAPEUTICS, INC. For: May 08 Filed by: Boulding Mark Elliott
May 12, 2026 5:20 PM - SEC Filing
Form 144 PTC THERAPEUTICS, INC. Filed by: Boulding Mark Elliott
May 8, 2026 4:16 PM - SEC Filing
PTC Therapeutics (PTCT) PT Raised to $94 at Morgan Stanley
May 8, 2026 8:10 AM - StreetInsider
PTC Therapeutics (PTCT) PT Raised to $82 at RBC Capital
May 8, 2026 7:36 AM - StreetInsider
PTC Therapeutics (PTCT) PT Raised to $95 at Wells Fargo
May 8, 2026 6:56 AM - StreetInsider
TD Cowen Upgrades PTC Therapeutics (PTCT) to Buy
May 8, 2026 2:57 AM - StreetInsider
Form 10-Q PTC THERAPEUTICS, INC. For: Mar 31
May 7, 2026 4:35 PM - SEC Filing
PTC Therapeutics (PTCT) Tops Q1 EPS by 43c, provides guidance
May 7, 2026 4:14 PM - StreetInsider
Form 8-K PTC THERAPEUTICS, INC. For: May 07
May 7, 2026 4:11 PM - SEC Filing
PTC Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results
May 7, 2026 4:01 PM - PR NewsWire
PTC Therapeutics to Participate in Upcoming Investor Conferences
May 4, 2026 8:00 AM - PR NewsWire
Form SCHEDULE 13G PTC THERAPEUTICS, INC. Filed by: VANGUARD CAPITAL MANAGEMENT LLC
April 30, 2026 12:09 PM - SEC Filing
Form SCHEDULE 13G PTC THERAPEUTICS, INC. Filed by: VANGUARD PORTFOLIO MANAGEMENT LLC
April 29, 2026 2:50 PM - SEC Filing
Form 8-K PTC THERAPEUTICS, INC. For: Apr 28
April 28, 2026 4:30 PM - SEC Filing
PTC Therapeutics reports positive results for Huntington's drug votoplam
April 28, 2026 4:05 PM - StreetInsider
PTC Therapeutics Reports Positive Topline Results from Month 24 Interim Analysis of PIVOT-HD Extension Study of Votoplam
April 28, 2026 4:05 PM - PR NewsWire
PTC Therapeutics to Report Results from PIVOT-HD Long Term Extension Study
April 28, 2026 9:28 AM - PR NewsWire
Form 4 PTC THERAPEUTICS, INC. For: Apr 21 Filed by: Klein Matthew B.
April 23, 2026 7:21 PM - SEC Filing
Full Article List
